Europe Defibrillators Market

Europe Defibrillators Market Size (2022 to 2027)

The size of the Defibrillators Market in Europe is predicted to grow USD 5.14 billion by 2027 from USD 3.60 billion in 2022, growing at a CAGR of 7.4% from 2022 to 2027.

The key factors driving Europe Defibrillators Market growth include technological advances such as the emergence of automatic external defibrillators (AEDs) in public access locations, an increased incidence of sudden cardiac arrest, and increased awareness worldwide. In Europe, many cases of heart failure are diagnosed each year, and the majority of them are deaths attributed to heart failure. Therefore, it is one of the primary drivers of the defibrillator market growth in this region. Also, increased incidence of other lifestyle habits, such as diabetes, atherosclerosis, stroke, hypertension, other unhealthy eating habits, and lack of activity, physical and smoking, are the leading causes of CHF. Also, an increasing elderly population should increase CHF prevalence, thereby driving the European defibrillators market growth.

The increasing appeal of medical care should drive the sales of home care defibrillators, such as portable external defibrillators and automatic external defibrillators (AEDs). In Europe, it creates the opportunity for defibrillators market, and the ability of a defibrillator to diagnose early ventricular tachycardia and ventricular defibrillation should drive its demand in the future period. However, the cost-effectiveness, safety, high accessibility, and clinical value of pre-treatment for sudden cardiac arrest enhance the technological advancement of the European defibrillator market.

The high cost of these devices is acting as a significant restraint to the growth of the European Defibrillators Market. Furthermore, the low reimbursement scenarios for defibrillation procedures, the lack of advanced medical infrastructure, the small physician and patient awareness of various treatment devices are the considerable threats that are further inhibiting the growth rate of the European defibrillators market.

This research report on the European defibrillators market has been segmented and sub-segmented into the following categories.

By Product:

• Implantable Defibrillators
  • Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
  • Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
  • Cardiac Resynchronization Therapy- Defibrillator (CRT-D)
• External defibrillators
  • Manual External Defibrillator
  • Automated External Defibrillator (AEDs)
  • Wearable Cardioverter Defibrillator (WCDs)

By End User:

• Hospitals
• Prehospital
• Public Access market
• Alternate Care Market
• Home

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Regionally, the European defibrillators market is the second-largest market share in the global defibrillators market. The UK is the leading market in this region. It captures 25% of the European defibrillators market.

KEY MARKET PLAYERS:

Some of the major players dominating the European defibrillators market profiled in the report are Medtronic PLC (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), LivaNova PLC (U.K.), Koninklijke Philips N.V. (Netherlands), ZOLL Medical Corporation (U.S.), Cardiac Science Corporation (U.S.), Physio-Control, Inc. (U.S.), and Nihon Kohden Corporation (Japan).